Pathway Health announces $3.5 million credit facility with its largest indirect beneficial shareholder
The company said it intends to use the available proceeds for general working capital and potential future acquisition purposes
Sector
Health
988 stories · page 29 of 50
Braxia Scientific lifts revenue and narrows loss in fiscal 2022 as it looks to "significantly" scale offerings
The medical research company, which provides ketamine treatments for depression and related disorders, said revenue came in at C$1.49 million for fiscal 2022 compared to revenue of C$1.008 million in the year to March 31, 2021
Irwin Naturals completes acquisition of New England Ketamine in move toward national mental health clinic network
This is the third acquisition that Irwin Naturals Emergence has completed in the past five months in an effort to build a national chain of mental health clinics providing psychedelic treatment using ketamine
Braxia Scientific appoints tech industry veteran Jason Wolkove as its CIO, Daniel Herrera as VP of R&D
The medical research company said both roles will be integral to executing the expansion of Braxia's clinical footprint, the rollout and expansion of novel ketamine and psilocybin therapy offerings, and the potential commercialization of fu
Venture Life gains pace after difficult year, as acquisitions bolster revenues
Self-care product developer still wary of supply chain issues in Chinese market
Wellbeing Digital Science says KGK subsidiary enters into research contract with Halucenex to test efficacy of psilocybin on PTSD
Under the agreement, KGK will perform research services, including the development of the clinical trial protocol, preparations towards the phase II clinical trials, data management and validation, statistical analysis and drafting of the f
IQ-AI signs partnership with Bayer to provide its software
IQ-AI said it is looking to accelerate the adoption of IB Clinic for healthcare providers through global networks
Mindset Pharma granted allowance for patent covering its short-duration novel psychedelic medications
"This notice of allowance reaffirms the strength of Mindset's IP position and facilitates our ongoing development of Family 2, a highly differentiated asset in our mission to help patients with unmet needs via the discovery of optimized psy
Planet 13 Holdings closes US$3.3M purchase of Florida land for staged cultivation facility
“We've strategically staged building materials on site over the past three months to build a world-class cultivation facility on an expedited timeline, with a full campus project planned for future phases,” said the company's co-CEO Larry S
Binovi Technologies hires new software development team to further develop neuro-visual performance platform
With the increase in technology and breakthroughs occurring in vision therapy, the company said it will focus on the redevelopment, update, and improvement of its Binovi Pro and Binovi Coach software and platform to make them more accessibl
FIVE at FIVE AU: ASX delivers best day in 21, Imugene gains almost 50%, is it time to watch lithium stocks and … why investors shouldn’t panic on rising rate
Here’s Proactive Australia’s round-up of the top local financial stories of the day, with helpful links taking you directly to the news.
MGC Pharmaceuticals shares rise after preliminary results indicate wide-ranging application of CimetrA as an anti-inflammatory treatment
Results indicate that CimetrA may have a wider-ranging application beyond the treatment of the symptoms of COVID-19, which has been the primary focus of clinical trials to date.
Roquefort Therapeutics acquiring biotech set up by Nobel Laureate
Oncogeni was founded by professor Sir Martin Evans, who was awarded the prize in 2007
Irwin Naturals plans to expand chain of psychedelic mental health centers into Georgia with acquisition of two clinics from Invictus Clinic
“We believe the strength of our brand will reduce the mental barrier for many people when they engage with this type of therapy,” said the company's CEO Klee Irwin
Wellbeing Digital Sciences appoints Natalie Dolphin as VP of marketing and investment relations
"Natalie is an outstanding addition to our Wellbeing team, having an exceptional record of leading successful marketing programs in her previous positions and will be able to focus attention on highlighting our high-quality assets and longe
Irwin Naturals expands operations into northeast with acquisition of Vermont-based clinic
The company noted that this is the eighth ketamine clinic it has added to its growing portfolio, which now covers four states, made up of acquired clinics and clinics under definitive agreements
Wellbeing Digital Sciences reports revenue of C$5.28M in nine months ended April 30, 2022
"2022 will be foundational year that will set the stage for Wellbeing to execute on its strategy in the future," said Najla Guthrie, Wellbeing's chief executive officer
Wellbeing Digital Sciences says KGK Science subsidiary announces positive results from study on GJ 191 supplement for osteoarthritis
"This clinically meaningful change has impact on this population of patients with self-reported knee pain," said Dr Mal Evans, chief scientific officer at KGK Science
Braxia Scientific expands Canadian mental health clinic footprint with newest location in Ontario’s Kitchener-Waterloo region
“Today's announcement is the first of what we intend to be a series of growth developments and acquisitions to our clinical network,” Braxia Scientific CEO Roger McIntyre said
Wellbeing Digital Sciences appoints chartered accountant Terry Zimaro as CFO
Zimaro brings over 20 years of public and private company experience in a wide range of finance functions, in particular specializing in high-growth environments, within various industries including psychedelics, the company said